Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist
about
Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammationThe IL-1 cytokine family and its role in inflammation and fibrosis in the lungIL-1 receptor 2 (IL-1R2) and its role in immune regulationDesign of a superior cytokine antagonist for topical ophthalmic useRegulation of serum amyloid A protein expression during the acute-phase responseCloning and characterization of the rainbow trout (Oncorhynchus mykiss) type II interleukin-1 receptor cDNA.The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.Deficient spontaneous in vitro apoptosis and increased tmTNF reverse signaling-induced apoptosis of monocytes predict suboptimal therapeutic response of rheumatoid arthritis to TNF inhibitionSoluble cytokine receptors: basic immunology and clinical applications.Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Cytokines in asthma.Different Regulation of Interleukin-1 Production and Activity in Monocytes and Macrophages: Innate Memory as an Endogenous Mechanism of IL-1 Inhibition.Fasting Induces IL-1 Resistance and Free-Fatty Acid-Mediated Up-Regulation of IL-1R2 and IL-1RASoluble cytokine receptors: novel immunotherapeutic agents.Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide.Soluble cytokine receptors in biological therapy.Role of cytokine signaling in group B Streptococcus-stimulated expression of human beta defensin-2 in human extraplacental membranesInterleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatmentInterleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty.Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.Identification of potential small molecule allosteric modulator sites on IL-1R1 ectodomain using accelerated conformational sampling method.Profile of soluble cytokine receptors in Crohn's disease.Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis.Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.Traumatic injury, early gene expression, and gram-negative bacteremia.Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaqueTrial Watch: Immunostimulatory cytokines.Differences of IL-1β Receptors Expression by Immunocompetent Cells Subsets in Rheumatoid Arthritis.Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors.Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP).The remedial effect of soluble interleukin-1 receptor type II on endometriosis in the nude mouse model.AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1.Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feedingTargeting IL-1 in Sjögren's syndrome.Mechanisms of spontaneous resolution of acute gouty inflammation.Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets.Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.Inhibition of proinflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark.
P2860
Q24673428-E7CCF9B9-EAA3-4C32-98E8-DB6616C06467Q26752849-231C6237-85AB-4301-819E-09763966B29DQ26826872-057C87B5-3877-4AC6-9623-307AD8DB7707Q27676526-A380D6BF-8B4E-47D9-A35D-80F2E4497D40Q28281545-89DE81D9-F501-4224-9276-0F4FF6350EDBQ30975538-ECD085FF-E7DA-407F-9719-6313BF8045ADQ33614316-02EAD7D1-54D9-49AC-A99D-B84CF77F3A1AQ33643146-A5DEA3B0-637A-4E50-B2EB-109FE5D0D524Q33688222-4F3F6D2E-2124-4E2F-8441-AB53FC860647Q33710807-F559FF22-3EC2-4A49-9B5B-44F76A482C45Q33717312-4892654B-341B-4426-8565-F06909C31337Q33774843-D408B894-812A-4B33-B3B6-4D59FED7E345Q33871150-4C45DE3C-7D0C-4D8D-ABC4-703406FBA27EQ34074749-18D46663-42EA-4D28-A9BF-C8BD68EFDE0CQ34727862-1ECD070B-AF54-489A-B383-47440AFDF4C6Q34779777-87843D67-9DE9-48CC-9301-174B83CB951CQ35071362-08EAC9E1-D395-4663-83B8-60CA3BB512CBQ35165663-F8051889-08F2-4DD9-8FD9-527D3C77FCF1Q35381016-96412458-860B-4CA8-B5BC-0A5FD7C17B58Q35467456-860874F7-6F8E-4D15-B365-71557A54BD6DQ35565839-CA3FD830-6C6A-4DEE-9363-9D1C894A5506Q35597272-EF2BDC28-3F62-41D9-A067-C46FA7BBA1C8Q35746291-7685C655-3563-45C6-A254-646E05FC5FE3Q35788358-B0B9DBF7-4072-43BF-A889-F2EF5EC5EF5DQ35889205-45ADE156-7483-471D-B295-8256C4AE70A0Q36023157-364630E0-BEBB-4566-B7F9-78B6A50E2031Q36057492-45DEF26A-580A-4978-A3CE-7BDC5D17CF86Q36089320-4DAACA03-B3EE-4FBD-95BE-ACC5B522E635Q36302597-15EF35D4-9ED6-42A1-847D-C1A2F05C2856Q36588937-05ED86A8-D058-47F7-B583-3A71CFD33614Q36681371-7A24F7BB-EE5C-4646-B259-E43812B1C009Q36835021-9A34440A-6577-438E-A278-FCB4E5A77E83Q36994635-6170B57D-BAFB-48FC-A905-FAFFC1BA304AQ36994761-591A30F2-0959-4638-8CC0-82A5094FFC98Q37141472-56DCB840-D6EC-470E-93CE-237A869DAFE4Q38074174-9710B1BE-6E28-4388-A300-7BC8EEE6969BQ38171695-B8A811F6-2B37-4676-9381-8C02D9C31187Q38656204-FD29719B-23A1-4185-8C95-8157A2B002ABQ38920969-E77707B7-1261-476F-A652-AADE4955BAEAQ39328762-6E77476F-A050-49EC-B009-6D866E0B341A
P2860
Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@ast
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@en
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@nl
type
label
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@ast
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@en
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@nl
prefLabel
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@ast
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@en
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@nl
P2093
P2860
P3181
P356
P1476
Soluble type II interleukin 1 ...... y for IL-1 receptor antagonist
@en
P2093
P2860
P304
P3181
P356
10.1073/PNAS.92.5.1714
P407
P577
1995-02-28T00:00:00Z